Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 5 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 2 |
| Introduction | 11 | 1 |
| Contract Manufacturing Organizations (CMO) an Upcoming Trend in Europe API Manufacturing | 12 | 5 |
| Introduction | 12 | 1 |
| How Does Outsourcing to CMOs Take Place? | 12 | 1 |
| Europe CMO Market Drivers | 13 | 1 |
| Availability of Low-Cost Skilled Manpower | 13 | 1 |
| Key Benefits of API Manufacturing Outsourcing in Europe | 14 | 1 |
| The Eastern European CMO Market | 15 | 2 |
| Europe Active Pharmaceutical Ingredients Market | 17 | 30 |
| Market Overview | 17 | 1 |
| API Classification | 17 | 1 |
| API Classification Based on Synthesis Routes | 18 | 1 |
| Synthetic API | 18 | 1 |
| Biotech API | 18 | 1 |
| Types based on Customer Base | 18 | 1 |
| Industry Structure | 19 | 1 |
| Europe API Market Drivers | 20 | 1 |
| Increased CMO Opportunities is Expected to Improve the Production of Generics and Fuel the Revenues of API in the Region | 20 | 1 |
| Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population are Driving the Growth of the European API Market | 20 | 1 |
| Attractiveness towards Biopharmaceutical Therapies Supports the Growth of the API Market in Europe | 20 | 1 |
| European Regulatory Framework Facilitating Development of Biosimilars | 20 | 1 |
| Differences in VAT rates on Pharma Products is Expected to Increase Parallel Trade in Europe | 20 | 1 |
| Europe API Market Restraints | 21 | 1 |
| Increased Consumption of Generics | 21 | 1 |
| Increasing Patent Expiries Hamper the Growth of the European API Market | 21 | 1 |
| Price Cuts Restrict the Revenue Growth of the European API Market | 21 | 3 |
| Europe API Total Revenue Analysis | 24 | 2 |
| Europe Revenue Share by Product Types | 26 | 1 |
| Europe Synthetic API Market Analysis | 27 | 1 |
| Europe Synthetic API Market Drivers | 27 | 1 |
| Healthy Growth in Generic Sectors Drives the Overall Growth of the Synthetic API Market in Europe | 27 | 1 |
| Growth in Central and Eastern European Countries to Boost the Growth of the Synthetic API Market | 27 | 1 |
| Europe Synthetic API Market Restraints | 27 | 1 |
| A Slowdown in the Growth of the Innovative Sector in Matured Markets will Restrict the Growth of the Synthetic API Market | 27 | 1 |
| High Competitiveness due to Fragmented API Market is a Significant Restraint for the Growth of the European Synthetic API Market | 27 | 1 |
| Europe Synthetic API Total Synthetic Revenue Analysis 2005-2017 | 28 | 2 |
| Europe Synthetic API Revenue Share Analysis by Countries 2011 | 30 | 2 |
| Europe Synthetic API Revenue Share Trend Analysis by Countries | 32 | 1 |
| European Synthetic API Market Revenue Share Analysis Based on Customer Base in 2011 | 33 | 1 |
| Europe Synthetic API Revenue Trend Analysis 2005-2017 | 34 | 2 |
| Europe Biotech API Market Analysis | 36 | 1 |
| Europe Biotech API Market Drivers | 36 | 1 |
| Increasing Uptake of Biopharmaceuticals or Specialty Drugs across Different Therapeutic Areas | 36 | 1 |
| Increasing Biologics Clusters | 36 | 1 |
| Europe Biotech API Market Restraints | 36 | 1 |
| The Complex Manufacturing Procedures for Biotech API is expected to Decrease the Frequency of New Entrants in to the Market | 36 | 1 |
| Complex Cost Structures in Outsourcing Biotech API Manufacturing Process | 36 | 1 |
| Europe Biotech API Revenue Analysis 2005-2017 | 37 | 1 |
| Europe Biotech API Revenue Share Analysis by Countries 2011 | 38 | 2 |
| Europe Biotech API Revenue Share Trend Analysis by Countries 2011 | 40 | 1 |
| Europe Biotech API Market Revenue Analysis by Customer Base | 41 | 1 |
| Europe Biotech API Market Revenue Share Analysis by Customer Base | 41 | 1 |
| Europe Patent Expiry of Leading Biologics | 42 | 3 |
| Europe API Revenue Split Up by Therapeutic Applications | 45 | 2 |
| Germany Active Pharmaceutical Ingredients Market | 47 | 11 |
| Germany API Market Overview | 47 | 1 |
| Germany Total API Revenue Analysis based on the synthesis routes 2005-2017 | 47 | 2 |
| Germany API Revenue Share Analysis by Product Types 2005-2017 | 49 | 1 |
| Germany API Revenue Analysis based on Customer Base | 50 | 1 |
| Germany Synthetic API Revenue Analysis by Customer Base, 2005-2017 | 50 | 2 |
| Germany Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017 | 52 | 1 |
| Germany Biotech API Revenue Analysis by Customer Base, 2005-2017 | 53 | 2 |
| Germany Biotech API Revenue Share Analysis by Customer Base, 2005-2017 | 55 | 1 |
| Germany API Revenue share Analysis by Therapeutic Applications | 56 | 2 |
| France Active Pharmaceutical Ingredients Market | 58 | 11 |
| France API Market Overview | 58 | 1 |
| France Total API Revenue Analysis Based on Synthesis Routes 2005-2017 | 58 | 2 |
| France API Revenue Share Analysis by Product Types 2005-2017 | 60 | 1 |
| France API Revenue Analysis based on Customer Base | 61 | 1 |
| France Synthetic API Revenue Analysis by Customer Base, 2005-2017 | 61 | 2 |
| France Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017 | 63 | 1 |
| France Biotech API Revenue Analysis by Customer Base, 2005-2017 | 64 | 2 |
| France Biotech API Revenue Share Analysis by Customer Base, 2005-2017 | 66 | 1 |
| France API Revenue share Analysis by Therapeutic Applications | 67 | 2 |
| Italy Active Pharmaceutical Ingredients Market | 69 | 11 |
| Italy API Market Overview | 69 | 1 |
| Italy Total API Revenue Analysis based on Synthesis Routes 2005-2017 | 69 | 2 |
| Italy API Revenue Share Analysis by Product Types 2005-2017 | 71 | 1 |
| Italy API Revenue Analysis based on Customer Base | 72 | 1 |
| Italy Synthetic API Revenue Analysis by Customer Base, 2005-2017 | 72 | 2 |
| Italy Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017 | 74 | 1 |
| Italy Biotech API Revenue Analysis by Customer Base, 2005-2017 | 75 | 2 |
| Italy Biotech API Revenue Share Analysis by Customer Base, 2005-2017 | 77 | 1 |
| Italy API Revenue share Analysis by Therapeutic Applications | 78 | 2 |
| The UK Active Pharmaceutical Ingredients Market | 80 | 11 |
| The UK API Market Overview | 80 | 1 |
| The UK Total API Revenue Analysis based on Synthesis Routes 2005-2017 | 80 | 2 |
| The UK API Revenue Share Analysis by Product Types 2005-2017 | 82 | 1 |
| The UK API Revenue Analysis based on Customer Base | 83 | 1 |
| The UK Synthetic API Revenue Analysis by Customer Base, 2005-2017 | 83 | 2 |
| The UK Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017 | 85 | 1 |
| The UK Biotech API Revenue Analysis by Customer Base, 2005-2017 | 86 | 2 |
| The UK Biotech API Revenue Share Analysis by Customer Base, 2005-2017 | 88 | 1 |
| The UK API Revenue share Analysis by Therapeutic Applications | 89 | 2 |
| Spain Active Pharmaceutical Ingredients Market | 91 | 11 |
| Spain API Market Overview | 91 | 1 |
| Spain Total API Revenue Analysis based on Synthesis Routes 2005-2017 | 91 | 2 |
| Spain API Revenue Share Analysis by Product Types 2005-2017 | 93 | 1 |
| Spain API Revenue Analysis based on Customer Base | 94 | 1 |
| Spain Synthetic API Revenue Analysis by Customer Base, 2005-2017 | 94 | 2 |
| Spain Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017 | 96 | 1 |
| Spain Biotech API Revenue Analysis by Customer Base, 2005-2017 | 97 | 2 |
| Spain Biotech API Revenue Share Analysis by Customer Base, 2005-2017 | 99 | 1 |
| Spain API Revenue share Analysis by Therapeutic Applications | 100 | 2 |
| Appendix | 102 | 4 |
| Abbreviations | 102 | 1 |
| Market Definitions | 102 | 1 |
| References | 102 | 1 |
| Methodology | 103 | 2 |
| Coverage | 103 | 1 |
| Secondary Research | 104 | 1 |
| Primary Research | 104 | 1 |
| Expert Panel Validation | 104 | 1 |
| Contact Us | 104 | 1 |
| Disclaimer | 105 | 1 |